share_log

Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday

Booz Allen Posts Upbeat Q3 Earnings, Joins Deckers Outdoor, Saia, Boyd Gaming And Other Big Stocks Moving Higher On Friday

Booz Allen發佈了樂觀的第三季度收益,週五股價走高,與deckers outdoor、saia、博伊德賭場和其他大股票一起上漲
Benzinga ·  2024/10/25 11:09

U.S. stocks were mixed, with the Nasdaq Composite gaining around 100 points on Friday.

週五,美國股市表現不一,納斯達克綜合指數上漲約100點。

Shares of Booz Allen Hamilton Holding Corporation (NYSE:BAH) rose sharply during Friday's session after the company reported better-than-expected quarterly EPS and sales.

紐約證券交易所上市公司 Booz Allen Hamilton Holding Corporation(NYSE:BAH)的股價週五大幅上漲,公司報告的季度每股收益和銷售額均好於預期。

Booz Allen Hamilton reported fiscal second-quarter adjusted EPS of $1.81, topping the analyst consensus estimate of $1.49. Quarterly sales of $3.15 billion, up 18% year-on-year, beat the street view of $2.97 billion. The backlog grew by 17.7%, reaching $41.3 billion, while the quarterly book-to-bill ratio stood at 2.61x.

Booz Allen Hamilton 報告的財季調整後每股收益爲1.81美元,超過分析師一致預期的1.49美元。季度銷售額爲31.5億美元,同比增長18%,超過街道預期的29.7億美元。待處理訂單增長17.7%,達到413億美元,而季度的賬面/賬單比率爲2.61倍。

Booz Allen Hamilton shares jumped 10% to $183.21 on Friday.

Booz Allen Hamilton 的股價週五飆升10%,達到183.21美元。

Here are some other big stocks recording gains in today's session.

以下是今天交易中漲幅較大的其他大股票。

  • ImmunityBio, Inc. (NASDAQ:IBRX) shares jumped 49.6% to $6.30. ImmunityBio recently announced it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed B-Cell Non-Hodgkin Lymphoma.
  • Fitell Corporation (NASDAQ:FTEL) gained 32.4% to $29.50.
  • Newell Brands Inc. (NASDAQ:NWL) climbed 22.8% to $8.81 after the company reported third-quarter financial results and raised its 2024 guidance.
  • ZEEKR Intelligent Technology Holding Limited (NASDAQ:ZK) gained 21.5% to $28.08.
  • Tapestry, Inc. (NYSE:TPR) gained 13.3% to $50.37 following a report alleging that a judge blocked the company's proposed acquisition of Capri. The company issued a statement on the ruling saying it intends to appeal the decision.
  • Sangamo Therapeutics, Inc. (NASDAQ:SGMO) rose 11.7% to $1.6650.
  • Trump Media & Technology Group Corp. (NASDAQ:DJT) gained 11.2% to $38.85.
  • AppFolio, Inc. (NASDAQ:APPF) gained 10.4% to $211.98 after the company reported better-than-expected quarterly financial results and raised its FY24 revenue guidance. Also, Piper Sandler maintained an Overweight rating on the stock.
  • Deckers Outdoor Corporation (NYSE:DECK) rose 10.2% to $167.53 after the company reported better-than-expected second-quarter financial results.
  • Digital Realty Trust, Inc. (NYSE:DLR) gained 10.2% to $182.01 after the company reported better-than-expected third-quarter FFO results and raised its FY24 FFO guidance.
  • Saia, Inc. (NASDAQ:SAIA) gained 9.2% to $452.58 following strong quarterly sales.
  • Boyd Gaming Corporation (NYSE:BYD) surged 6.7% to $68.60 after the company reported better-than-expected quarterly financial results.
  • ImmunityBio, Inc.(NASDAQ:IBRX)的股價飆升49.6%,至6.30美元。ImmunityBio 最近宣佈,已對複發性b細胞非霍奇金淋巴瘤的CAR-Nk細胞療法進行了第一階段臨床研究的投藥。
  • Fitell Corporation(NASDAQ:FTEL)漲幅達32.4%,報29.50美元。
  • Newell Brands Inc.(NASDAQ:NWL)的股價上漲22.8%,至8.81美元,公司發佈第三季度財務業績並提高了2024年的指引。
  • 極氪智能科技控股有限公司(納斯達克:ZK)上漲21.5%,至28.08美元。
  • Tapestry公司(紐交所:TPR)漲幅13.3%,至50.37美元,據報道稱,一位法官阻止了該公司對Capri的擬議收購。 該公司就裁決發表了一份聲明,表示打算對該決定提出上訴。
  • Sangamo Therapeutics公司(納斯達克:SGMO)上漲11.7%,至1.6650美元。
  • 特朗普媒體與科技集團公司(納斯達克:DJT)上漲11.2%,至38.85美元。
  • AppFolio公司(納斯達克:APPF)上漲10.4%,至211.98美元,該公司報告了好於預期的季度財務業績,並提高了其FY24營收指導。此外,Piper Sandler對該股維持增持評級。
  • deckers outdoor公司(紐交所:DECK)上漲10.2%,至167.53美元,該公司報告了好於預期的第二季度財務業績。
  • Digital Realty Trust公司(紐交所:DLR)上漲10.2%,至182.01美元,該公司報告了好於預期的第三季度FFO業績,並提高了其FY24 FFO指引。
  • saia公司(納斯達克:SAIA)上漲9.2%,至452.58美元,緊隨強勁的季度銷售之後。
  • 博伊德賭場公司(紐交所:比亞迪)報告超出預期的季度財務業績後,股價大漲6.7%,達到68.60美元。

Now Read This:

現在閱讀這個:

This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

這位PPL 分析師開始對看好的說明;以下是週五的前5個初始覆蓋

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論